Therefore, through the inhibition of the acetylcholinesterase, these lignans may prevent memory loss in AD patients, hence providing a nutritional strategy to complement the use of synthetically derived acetylcholinesterase inhibitors. The gene discussed is ACHE; the disease is Alzheimer disease.